BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10748874)

  • 1. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis.
    Mutter GL; Wada H; Faquin WC; Enomoto T
    Mol Pathol; 1999 Oct; 52(5):257-62. PubMed ID: 10748874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
    Jovanovic AS; Boynton KA; Mutter GL
    Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia.
    Sun H; Enomoto T; Shroyer KR; Ozaki K; Fujita M; Ueda Y; Nakashima R; Kuragaki C; Ueda G; Murata Y
    Diagn Mol Pathol; 2002 Dec; 11(4):204-11. PubMed ID: 12459636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras mutations in endometrial carcinomas with microsatellite instability.
    Lagarda H; Catasus L; Arguelles R; Matias-Guiu X; Prat J
    J Pathol; 2001 Feb; 193(2):193-9. PubMed ID: 11180166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
    Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
    Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules).
    Brachtel EF; Sánchez-Estevez C; Moreno-Bueno G; Prat J; Palacios J; Oliva E
    Am J Surg Pathol; 2005 Oct; 29(10):1322-9. PubMed ID: 16160475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras point mutations in spontaneously occurring endometrial adenocarcinomas in the Donryu rat.
    Tanoguchi K; Yaegashi N; Jiko K; Maekawa A; Sato S; Yajima A
    Tohoku J Exp Med; 1999 Oct; 189(2):87-93. PubMed ID: 10775052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer.
    Mutter GL; Boynton KA; Faquin WC; Ruiz RE; Jovanovic AS
    Cancer Res; 1996 Oct; 56(19):4483-6. PubMed ID: 8813144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of K-ras mutations in cancerous lesions of human endometrium.
    Semczuk A; Berbéc H; Kostuch M; Kotarski J; Wojcierowski J
    Eur J Gynaecol Oncol; 1997; 18(1):80-3. PubMed ID: 9061333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
    Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
    Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the p53 tumor suppressor gene and activation of c-K-ras-2 protooncogene in endometrial adenocarcinoma from Colorado.
    Enomoto T; Fujita M; Inoue M; Nomura T; Shroyer KR
    Am J Clin Pathol; 1995 Feb; 103(2):224-30. PubMed ID: 7856567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K-ras point mutation occurs in the early stage of carcinogenesis in lung cancer.
    Sagawa M; Saito Y; Fujimura S; Linnoila RI
    Br J Cancer; 1998 Mar; 77(5):720-3. PubMed ID: 9514049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.
    Vassileva V; Millar A; Briollais L; Chapman W; Bapat B
    Cancer Res; 2002 Jul; 62(14):4095-9. PubMed ID: 12124347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.
    Mutter GL; Lin MC; Fitzgerald JT; Kum JB; Baak JP; Lees JA; Weng LP; Eng C
    J Natl Cancer Inst; 2000 Jun; 92(11):924-30. PubMed ID: 10841828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare occurrence of p53 and ras gene mutations in preneoplastic and neoplastic mouse endometrial lesions induced by N-methyl-N-nitrosourea and 17 beta-estradiol.
    Murase T; Niwa K; Morishita S; Itoh N; Mori H; Tanaka T; Tamaya T
    Cancer Lett; 1995 Jun; 92(2):223-7. PubMed ID: 7600534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in sporadic endometrial carcinoma.
    Duggan BD; Felix JC; Muderspach LI; Tourgeman D; Zheng J; Shibata D
    J Natl Cancer Inst; 1994 Aug; 86(16):1216-21. PubMed ID: 8040889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.